Drug resistance evaluation in novel 3D in vitro model-Reference-Cited by-同舟云学术

Drug resistance evaluation in novel 3D in vitro model

Published:2021-06 Issue: Volume:138 Page:111536
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Nowacka Marta,Sterzynska Karolina,Andrzejewska Malgorzata,Nowicki Michal,Januchowski Radoslaw

Funder

Narodowe Centrum Nauki

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference90 articles.

1. Ovarian cancer, cancer stem cells and current treatment strategies: a potential role of magmas in the current treatment methods;Ahmed;Cells,2020

2. Ovarian cancer: a heterogeneous disease;Kossaï;Pathobiology,2018

3. WHO classification of tumours of female reproductive organs - NLM Catalog - NCBI, 2014. https://www.ncbi.nlm.nih.gov/nlmcatalog/101656343 (Accessed 15 May 2020).

4. Ovarian Cancer;Cho;Annu. Rev. Pathol. Mech. Dis.,2009

5. Overcoming resistance to platinum-based drugs in ovarian cancer by salinomycin and its derivatives—an in vitro study;Michalak;Molecules,2020

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photothermal induction of pyroptosis in malignant glioma spheroids using (16-mercaptohexadecyl)trimethylammonium bromide-modified cationic gold nanorods;Colloids and Surfaces B: Biointerfaces;2024-11

2. Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them;PeerJ;2024-08-29

3. Assessing Drug Uptake and Response Differences in 2D and 3D Cellular Environments Using Stimulated Raman Scattering Microscopy;Analytical Chemistry;2024-08-26

4. Functionalized Magnetic Fe3O4 Nanoparticles for Targeted Methotrexate Delivery in Ovarian Cancer Therapy;International Journal of Molecular Sciences;2024-08-22

5. Growing Role of 3D In Vitro Cell Cultures in the Study of Cellular and Molecular Mechanisms: Short Focus on Breast Cancer, Endometriosis, Liver and Infectious Diseases;Cells;2024-06-18